hobbs.qxp 26/2/08 9:33 am Page 41
Methods for Detection of Trichomonas vaginalis
study, over 70% of male partners of women with trichomoniasis were readily available technology. Rapid tests also provide a more sensitive
infected with T. vaginalis, emphasising the importance of sexual partner immediate point-of-care diagnosis for trichomoniasis and can be
notification and treatment.
performed in clinics with limited laboratory capabilities. With the advent of
the commercially available APTIMA TV test, clinicians in settings employing
Unfortunately, in many clinics and medical centres no diagnostic test APTIMA NAATs to detect gonococcal and chlamydial infections can now
beyond wet-mount microscopy is available. Although such testing can obtain results for N. gonorrhoeae, C. trachomatis and T. vaginalis from a
facilitate immediate diagnosis of infected women, clinicians should no single specimen from men or women. Continued development and more
longer consider wet-mount microscopy as an adequate diagnostic method widespread use of newer sensitive diagnostic tests, coupled with increased
for evaluation of T. vaginalis infection. Culture using the InPouch TV system awareness of T. vaginalis as an important genito-urinary pathogen in men
is convenient and affordable (approximately US$3 per test device) and uses and women, are essential for control of trichomoniasis. ■
1. World Health Organization, Global Prevalence and Incidence of 23. Kaydos-Daniels SC, Miller WC, Hoffman I, et al., Validation of a 45. Kaydos-Daniels SC, Miller WC, Hoffman I, et al., The use of
Selected Curable Sexually Transmitted Infections, 2001. urine-based PCR-enzyme-linked immunosorbent assay for use in specimens from various genito-urinary sites in men, to detect
2. Cates W Jr, Estimates of the incidence and prevalence of clinical research settings to detect Trichomonas vaginalis in men, Trichomonas vaginalis infection, J Infect Dis, 2004;189:1926–31.
sexually transmitted diseases in the US, American Social Health J Clin Microbiol, 2003;41:318–23. 46. Brown HL, Fuller DD, Jasper LT, et al., Clinical evaluation of
Association Panel, Sex Trans Dis, 1999;26:S2–7. 24. Krieger JN, Verdon M, Siegel N, Holmes KK, Natural history of affirm VPIII in the detection and identification of Trichomonas
3. Sorvillo F, Smith L, Kerndt P, Ash L, Trichomonas vaginalis, HIV urogenital trichomoniasis in men, J Urol, 1993;149:1455–8. vaginalis, Gardnerella vaginalis and Candida species in
and African-Americans, Emerg Infect Dis, 2001;7:927–32. 25. Kingston MA, Bansal D, Carlin EM, ‘Shelf life’ of Trichomonas vaginitis/vaginosis, Infect Dis Obstet Gynecol, 2004;12:17–21.
4. Niccolai LM, Kopicko JJ, Kassie A, et al., Incidence and vaginalis, Int J AIDS, 2003;14:28–9. 47. Brown HL, et al., Evaluation of the Affirm Ambient Temperature
predictors of reinfection with Trichomonas vaginalis in 26. Aslan DL, McKeon DM, Stelow EB, et al., The diagnosis of Transport System for the detection and identification of
HIV-infected women, Sex Trans Dis, 2000;27:284–8. Trichomonas vaginalis in liquid-based Pap tests: Morphological Trichomonas vaginalis, Gardnerella vaginalis and Candida species
5. Krieger JN, Alderete JF, Trichomonas vaginalis and characteristics, Diagn Cytopathol, 2005;32:253–9. from vaginal fluid specimens, J Clin Microbiol, 2001;39:197–9.
trichomoniasis, Sex Trans Dis, 2000;587–604. 27. Buchmayer S, Sparen P, Cnattingius S, Signs of infection in Pap 48. Huppert JS, et al., Use of an immunochromatographic assay for
6. Minkoff HL, et al., Prevalence and incidence of gynecological smears and risk of adverse pregnancy outcome, Paediatr Perinat rapid detection of Trichomonas vaginalis in vaginal specimens,
disorders among women infected with HIV, Amer J Obstet Gynecol, Epidemiol, 2003;17:340–46. J Clin Microbiol, 2005;43:684–7.
1999;180:824–36. 28. Lara-Torre E, Pinkerton JS, Accuracy of detection of Trichomonas 49. Kaydos SC, Swygard H, et al., Development and validation of a
7. Cotch MF, Pastorek JG 2nd, Nugent RP, et al., Trichomonas vaginalis organisms on a liquid-based papanicolaou smear, Am J PCR-based enzyme-linked immunosorbent assay with urine for
vaginalis associated with low birth weight and pre-term Obstet Gynecol, 2003;188:354–6. use in clinical research settings to detect Trichomonas vaginalis,
delivery. The Vaginal Infections and Prematurity Study Group, 29. Burja IT, Shurbaji MS, Clinical impact of identifying Trichomonas in women, J Clin Microbiol, 2002;40:89–95.
Sex Trans Dis, 1997;24:353–60. vaginalis on cervicovaginal (Papanicolaou) smears, Diagn 50. Crucitti T, et al., Comparison of culture and different PCR
8. Pastorek JG, et al., Clinical and microbiological correlates of Cytopathol, 2001;24:195–9. assays for detection of Trichomonas vaginalis in self-collected
vaginal trichomoniasis during pregnancy. The Vaginal Infections 30. Lobo TT, Feijo G, Carvalho SE, et al., A comparative evaluation vaginal swab specimens, Sex Transm Infect, 2003;79:393–8.
and Prematurity Study Group, Clin Infect Dis, 1996;23:1075–80. of the Papanicolaou test for the diagnosis of trichomoniasis, 51. Hardick J, et al., Use of the Roche LightCycler instrument in a
9. Sayed el-Ahl SA, et al., A preliminary study on the relationship Sex Transm Dis, 2003;30:694–9. realtime PCR for Trichomonas vaginalis in urine samples from
between Trichomonas vaginalis and cervical cancer in Egyptian 31. Wiese W, Patel SR, Patel SC, et al., A meta-analysis of the females and males, J Clin Microbiol, 2003;41:5619–22.
women, J Egypt Soc Parasitol, 2002;32:167–78. Papanicolaou smear and wet-mount for the diagnosis of 52. Hadgu A, Discrepant analysis: a biased and an unscientific
10. Garland SM, Tabrizi SN, Chen S, et al., Prevalence of sexually vaginal trichomoniasis, Am J Med, 2000;108:301–8. method for estimating test sensitivity and specificity, J Clin
transmitted infections in female attendees of a sexually 32. Clark CG, Diamond LS, Methods for cultivation of luminal parastic Epidemiol, 1999;52:1231–7.
transmitted diseases clinic in Ulaanbaatar, Mongolia, Infect Dis protists of clinical importance, Clin Microbiol Rev, 2002;15:329–41. 53. McAdam AJ, Discrepant analysis: how can we test a test?,
Obstet Gynecol, 2001;9:143–6. 33. Borchardt KA, Zhang MZ, et al., A comparison of the sensitivity J Clin Microbiol, 2000;38:2027–9.
11. Viikki M, et al., Gynaecological infections as risk determinants of of the InPouch TV, Diamond’s and Trichosel media for detection 54. Miller WC, Bias in discrepant analysis: when two wrongs don’t
subsequent cervical neoplasia, Acta Oncologica, 2000;39:71–5. of Trichomonas vaginalis, Genitourin Med, 1997;73:297–8. make a right, J Clin Epidemiol, 1998;51:219–31.
12. Zhang ZF, et al., Trichomonas vaginalis and cervical cancer. A 34. Stary A, Kuchinka-Koch A, Teodorowicz L, Detection of 55. Staquet M, et al., Methodology for the assessment of new
prospective study in China, Ann Epidemiol, 1995;5:325–32. Trichomonas vaginalis on modified Columbia agar in the routine dichotomous diagnostic tests, J Chron Dis, 1981;34:599–610.
13. Yap EH, Ho TH, et al., Serum antibodies to Trichomonas laboratory, J Clin Microbiol, 2002;40:3277–80. 56. Lawing LF, Hedges SR, Schwebke JR, Detection of
vaginalis in invasive cervical cancer patients, Genitourin Med, 35. Schirm J, Bos PA, Roozeboom-Roelfsema IK, et al., Trichomonas trichomonosis in vaginal and urine specimens from women by
1995;71:402–4. vaginalis detection using realtime TaqMan PCR, J Microbiol culture and PCR, J Clin Microbiol, 2000;38:3585–8.
14. Gram IT, Macaluso M, Churchill J, Stalsberg H, Trichomonas Methods, 2007;68:243–7. 57. Hardick A, Hardick J, Wood BJ, Gaydos C, Comparison between
vaginalis (TV) and human papillomavirus (HPV) infection and 36. Huppert JS, Mortensen JE, Reed JL, et al., Rapid antigen testing the Gen-Probe transcription-mediated amplification Trichomonas
the incidence of cervical intraepithelial neoplasia (CIN) grade III, compares favourably with transcription-mediated amplification vaginalis research assay and realtime PCR for Trichomonas
Cancer Causes Control, 1992;3:231–6. assay for the detection of Trichomonas vaginalis in young vaginalis detection using a Roche LightCycler instrument with
15. Gottlieb SL, Douglas JM Jr., Foster M, et al., Incidence of herpes women, Clin Infect Dis, 2007;45:194–8. female self-obtained vaginal swab samples and male urine
simplex virus type 2 infection in five sexually transmitted 37. Caliendo A, Jordan J, Green A, et al., Realtime PCR improves samples, J Clin Microbiol, 2006;44:4197–9.
disease (STD) clinics and the effect of HIV/STD risk-reduction detection of Trichomonas vaginalis infection compared with 58. Mohamed OA, et al., Urine proves a poor specimen for culture of
counselling, J Infect Dis, 2004;190:1059–67. culture using self-collected vaginal swabs, Infect Dis Obstet Trichomonas vaginalis in women, Sex Trans Inf, 2001;77:78–9.
16. Boselli F, Chiossi G, Bortolamasi M, Gallinelli A, Prevalence and Gynecol, 2005;13:145–50. 59. Hardick AJ, et al., Comparison of cervical samples to vaginal
determinants of genital shedding of herpes simplex virus among 38. Beverly AL, et al., Viability of Trichomonas vaginalis in transport samples for the detection of Trichomonas vaginalis using a
women attending Italian colposcopy clinics, Eur J Obstet medium, J Clin Microbiol, 1999;37:3749–50. Gen-Probe research assay for rRNA, General Meeting of the
Gynecol Reprod Biol, 2005;118:86–90. 39. Schwebke JR, Venglarik MF, Morgan SC, Delayed versus American Society for Microbiology, 2005.
17. Wasserheit JN, Epidemiological synergy. Interrelationships immediate bedside inoculation of culture media for diagnosis of 60. Wendel KA, Erbelding EJ, Gaydos CA, Rompalo AM, Use of
between HIV infection and other sexually transmitted diseases, vaginal trichomonosis, J Clin Microbiol, 1999;37:2369–70. urine polymerase chain reaction to define the prevalence and
Sex Transm Dis, 1992;19:61–77. 40. Swygard H, Miller WC, et al., Targeted screening for Trichomonas clinical presentation of Trichomonas vaginalis in men attending
18. Laga M, Manoka, et al, Non-ulcerative sexually transmitted vaginalis with culture using a two-step method in women an STD clinic, Sex Transm Infect, 2003;79:151–3.
diseases as risk factors for HIV-1 transmission in women: results presenting for STD evaluation, Sex Transm Dis, 2004;31:659–64. 61. Hobbs MM, et al., Trichomonas vaginalis as a cause of urethritis
from a cohort study, AIDS, 1993;7:95–102. 41. Sena AC, Miller WC, et al., Trichomonas vaginalis infection in in Malawian men, Sex Trans Dis, 1999;26:381–7.
19. Laga M, Nzila N, Goeman J, The interrelationship of sexually male sexual partners: implications for diagnosis, treatment and 62. Bianchi A, Bogard M, Cessot G, et al., Kinetics of Chlamydia
transmitted diseases and HIV infection: implications for the prevention, Clin Infect Dis, 2007;44:13–22. trachomatis clearance in patients with azithromycin, as assessed
control of both epidemics in Africa, Aids, 1991;(Suppl. 1):S55–63. 42. Hobbs MM, Lapple DM, Lawing LF, et al., Methods for by first void urine testing by PCR and transcription-mediated
20. Buve A, et al., The epidemiology of trichomoniasis in women in detection of Trichomonas vaginalis in the male partners of amplification, Sex Transm Dis, 1998;25:366–7.
four African cities, Aids, 2001;(Suppl. 4):S89–96. infected women: implications for control of trichomoniasis, 63. Bachmann LH, Desmond RA, et al., Duration of persistence of
21. McClelland RS, Sangare L, Hassan WM, et al., Infection with J Clin Microbiol, 2006;44:3994–9. gonococcal DNA detected by ligase chain reaction in men and
Trichomonas vaginalis increases the risk of HIV-1 acquisition, 43. Schwebke JR, Lawing LF, Improved detection by DNA women following recommended therapy for uncomplicated
J Infect Dis, 2007;195:698–702. amplification of Trichomonas vaginalis in males, J Clin Microbiol, gonorrhea, J Clin Microbiol, 2002;40:3596–3601.
22. Price MA, Miller WC, et al., Trichomoniasis in men and HIV 2002;40:3681–3. 64. Centers for Disease Control and Prevention, Sexually transmitted
infection: Data from two outpatient clinics at Lilongwe Central 44. Krieger JN, et al., Risk assessment and laboratory diagnosis of diseases treatment guidelines 2006, MMWR, 2006;55:1–100.
Hospital, Malawi, J Infect Dis, 2004;190:1448–55. trichomoniasis in men, J Infect Dis, 1992;166:1362–6.
EUROPEAN GENITO-URINARY DISEASE 2007 41
| Page 2
| Page 3
| Page 4
| Page 5
| Page 6
| Page 7
| Page 8
| Page 9
| Page 10
| Page 11
| Page 12
| Page 13
| Page 14
| Page 15
| Page 16
| Page 17
| Page 18
| Page 19
| Page 20
| Page 21
| Page 22
| Page 23
| Page 24
| Page 25
| Page 26
| Page 27
| Page 28
| Page 29
| Page 30
| Page 31
| Page 32
| Page 33
| Page 34
| Page 35
| Page 36
| Page 37
| Page 38
| Page 39
| Page 40
| Page 41
| Page 42
| Page 43
| Page 44
| Page 45
| Page 46
| Page 47
| Page 48
| Page 49
| Page 50
| Page 51
| Page 52
| Page 53
| Page 54
| Page 55
| Page 56
| Page 57
| Page 58
| Page 59
| Page 60
| Page 61
| Page 62
| Page 63
| Page 64
| Page 65
| Page 66
| Page 67